Search Results

< Prev
1 of 1
Next >

News Releases

May 15, 2013, 02:30 ET

Bayer Initiates Phase III Trial of Stivarga® (regorafenib) Tablets in Patients with Advanced Liver Cancer

Bayer HealthCare announced today that patient enrollment is underway for RESORCE (Regorafenib after Sorafenib in Patients with Hepatocellular Carcinoma), an international Phase III trial to evaluate the efficacy and safety of Stivarga® (regorafenib) tablets for the treatment of patients with...

More news about: Bayer HealthCare Pharmaceuticals Inc. , Bayer HealthCare LLC , Bayer AG
May 10, 2013, 13:05 ET

Bayer HealthCare Committed to Growing Animal Health Business

Bayer HealthCare LLC Animal Health division expanded their product portfolio and introduced seven products to the market as the company continues the integration process following the recent acquisition of Teva Animal Health Inc. based in St. Joseph, MO. Seven DVM® dermatology products...

More news about: Bayer HealthCare LLC , Teva Animal Health Inc.
May 07, 2013, 09:00 ET

Colorado State University Student Wins Bayer Excellence in Communication Award National Scholarship

Bayer HealthCare LLC, Animal Health Division is proud to announce that Jessica Bridge, a junior at Colorado State University's College of Veterinary Medicine & Biomedical Sciences, is the inaugural national winner of the Bayer Excellence in Communication Award. Bayer HealthCare Animal...

More news about: Bayer HealthCare LLC
May 02, 2013, 09:00 ET

Bayer HealthCare Introduces Seresto™, Offering Easy-To-Use Flea and Tick Control for Dogs or Cats that Lasts Eight Months

Bayer HealthCare LLC Animal Health Division has now provided dog and cat owners the same performance they expect from a monthly flea and tick topical in an easy-to-use, convenient collar that protects for eight months. Seresto™, manufactured by Bayer, is an effective flea and tick...

More news about: Bayer HealthCare LLC
Apr 30, 2013, 11:09 ET

Ryan & Maniskas, LLP Announces Investigation of Conceptus, Inc.

Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/cpts) is investigating potential claims against the board of directors of Conceptus, Inc. ("Conceptus" or the "Company") (NASDAQ: CPTS) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to...

More news about: Ryan & Maniskas, LLP , Conceptus, Inc. , Bayer HealthCare LLC
Apr 29, 2013, 17:53 ET

Acquisition of Conceptus, Inc. by Bayer HealthCare LLC May Not Be in the Best Interests of Conceptus Shareholders

Shareholder rights attorneys at Robbins Arroyo LLP are investigating the acquisition of Conceptus, Inc. (NASDAQ: CPTS) by Bayer HealthCare LLC. On April 29, 2013, Bayer announced the signing of a merger agreement with Conceptus whereby Bayer will launch a public tender offer to acquire...

More news about: Robbins Arroyo LLP , Conceptus, Inc. , Bayer HealthCare LLC
Apr 29, 2013, 16:52 ET

Harwood Feffer LLP Announces Investigation of Conceptus, Inc.

Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Conceptus, Inc. ("Conceptus" or the "Company") (NASDAQ: CPTS) concerning the proposed acquisition of the Company by Bayer Healthcare LLC ("Bayer") in a transaction valued at approximately...

More news about: Harwood Feffer LLP , Conceptus, Inc. , Bayer Healthcare LLC
Apr 29, 2013, 10:39 ET

Conceptus, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bayer HealthCare LLC

Bernstein Liebhard LLP is investigating whether the Board of Directors of Conceptus, Inc. ("Conceptus" or the "Company") (NASDAQ: CPTS) breached its fiduciary duty to its shareholders in agreeing to sell Conceptus to Bayer HealthCare LLC. (Logo:...

More news about: Bernstein Liebhard LLP , Bayer HealthCare LLC , Conceptus, Inc.